Stock RCUS ARCUS BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Arcus Biosciences, Inc.

Equities

RCUS

US03969F1093

Real-time Estimate Cboe BZX
Other stock markets
 18:15:33 29/04/2024 BST 		5-day change 1st Jan Change
15.88 USD +2.12% Intraday chart for Arcus Biosciences, Inc. +7.83% -17.12%
03-12 Transcript : Arcus Biosciences, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 02:35 PM
02-29 Arcus Biosciences Insider Sold Shares Worth $1,177,967, According to a Recent SEC Filing MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting
BU
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update
BU
Arcus Biosciences Announces New Employment Inducement Grants
BU
Arcus Biosciences Announces New Employment Inducement Grants
BU
Transcript : Arcus Biosciences, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 02:35 PM
Arcus Biosciences Announces New Employment Inducement Grants
BU
Arcus Biosciences Insider Sold Shares Worth $1,177,967, According to a Recent SEC Filing
MT
Arcus Biosciences Insider Sold Shares Worth $543,187, According to a Recent SEC Filing
MT
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
BU
Arcus Biosciences Announces New Employment Inducement Grants
BU
Transcript : Arcus Biosciences, Inc. Presents at Citi 2024 Virtual Oncology Leadership Summit, Feb-22-2024 11:00 AM
Transcript : Arcus Biosciences, Inc., Q4 2023 Earnings Call, Feb 21, 2024
Earnings Flash (RCUS) ARCUS BIOSCIENCES Reports Q4 Revenue $31M
MT
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
BU
Arcus Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Arcus Biosciences Announces New Employment Inducement Grants
BU
Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates
BU
Gilead and Arcus Announce Amended Collaboration Agreement
CI
Global markets live: WPP UPS GM, Super Micro Computer, Microsoft...
Our Logo
Mizuho Adjusts Arcus Biosciences' Price Target to $42 From $51, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RCUS Stock
  4. News Arcus Biosciences, Inc.